| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 02/24/2005 | US20050043269 Pharmaceutically active uridine esters |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043224 Administering to patient a pharmaceutical preparation comprising at least one chemoprotective inducing agent and a vehicle for delivering chemoprotective inducing agent to cells lining hair follicles, in an amount and for a time effective to reduce or prevent hair loss |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042354 Antiradicals and fat compositions, foods, drinks, drugs or feeds containing the antiradicals |
| 02/24/2005 | US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome |
| 02/24/2005 | CA2534922A1 Composition comprising a zeolite compound for treatment of diseases |
| 02/23/2005 | EP1507544A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/23/2005 | EP1507527A2 Methods for enhancing motor performance and/or endurance |
| 02/23/2005 | EP1507515A2 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | CN1585768A Pyrazole derivatives as psychopharmaceuticals |
| 02/23/2005 | CN1584031A Preparation of effective expressed human DNA enzyme repression factors and their uses in medicines against oxidation and its use against generation of blood vessels |
| 02/23/2005 | CN1583122A Oral taken medicine for snakebite by long noded pit viper |
| 02/23/2005 | CN1583108A Health care product of hippophae rhamnoides oil |
| 02/23/2005 | CN1583054A Detoxic defatting preparation and its preparation |
| 02/23/2005 | CN1583019A Anti-oxidation health care nutrient oil |
| 02/23/2005 | CN1582904A Use of methyl aldehyde in preparation of medicines to preventing animals from toxic diseases |
| 02/22/2005 | US6858235 Antioxidant composition and method of preparation thereof |
| 02/17/2005 | US20050038010 Substituted heterocyclic compounds and methods of use |
| 02/17/2005 | US20050037984 Administering protein kinase C activator |
| 02/17/2005 | US20050037097 Pyruvate enriched onion extract |
| 02/17/2005 | US20050037095 Compositions enriched in anthocyanins |
| 02/17/2005 | US20050037069 Solid and stable creatine/citric acid composition(s) and compositions carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 02/17/2005 | DE10332011A1 Verwendung von Glaszusammensetzungen zum Erzielen eines antioxidativen Effektes Use of glass compositions to achieve an anti-oxidative effect |
| 02/16/2005 | EP1506958A1 Process for producing shogaol and intermediates for the synthesis thereof |
| 02/16/2005 | EP1506951A1 Preparation and application of transhintotalphenolic acid |
| 02/16/2005 | EP1506214A1 6-11 bicyclic ketolide derivatives |
| 02/16/2005 | EP1506192A1 Substituted pyrroline kinase inhibitors |
| 02/16/2005 | EP1506186A1 Substituted heterocyclic compounds and methods of use |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1505984A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1296698A4 Therapeutic agents - ii |
| 02/16/2005 | EP1296697A4 Therapeutic agents - i |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582280A 3, 4-di-substituted pyridazinediones as CXC chemokine receptor antagonists |
| 02/16/2005 | CN1582169A Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 02/16/2005 | CN1582159A Preparing material of flavanol wood lipid with increased solubility |
| 02/16/2005 | CN1582147A Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 02/16/2005 | CN1580064A Tangeritin extracting technique |
| 02/16/2005 | CN1579534A Glossy ganoderma in siberia and its anti-Hiv and radical-eliminating function |
| 02/16/2005 | CN1579526A External medicine for bite wound by long-noded pit viper and preparation method |
| 02/16/2005 | CN1579516A Use of Herba Artemisiae Vulgaris potato |
| 02/16/2005 | CN1579481A Medicine for treating fluorine, lead, mercury, arsenic poisoning and its production method |
| 02/16/2005 | CN1579456A Extract of shilianhua and its function of beauty and redicals scavenging agent |
| 02/16/2005 | CN1579385A New Preparation of Gantaile |
| 02/16/2005 | CN1579253A Amino-acid salt drink and amino-acid salt tonic |
| 02/16/2005 | CN1189172C N-acetyl-5, 6-dimethoxytryptamine for preparing medicine resisting oxidation free radical |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855338 Anti-tumor therapies comprising a combination of a cartilage extract and an anti-neoplastic agent providing high efficacy and low toxic side effects |
| 02/14/2005 | CA2477359A1 Pyruvate enriched onion extract |
| 02/10/2005 | WO2005012293A1 Phenylazole compounds, production process, and antioxidants |
| 02/10/2005 | WO2005011712A1 Natural astaxanthin extract reduces dna oxidation |
| 02/10/2005 | CA2534263A1 Phenylazole compounds, production process and antioxidants |
| 02/09/2005 | EP1503800A1 Treatment and prevention of tissue damage |
| 02/09/2005 | EP1503794A1 Methods of treatement using ctla-4 antibodies |
| 02/09/2005 | EP1503773A1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 02/09/2005 | EP1503772A1 Soluble composition containing sporopollenin and the use thereof |
| 02/09/2005 | EP1503767A2 Compositions and methods for treatment of vitamin d deficiency |
| 02/09/2005 | EP1503748A1 Drugs for mitigating taxane-induced neurotoxicity |
| 02/09/2005 | EP1420802A4 Increased solubility flavanolignan preparations |
| 02/09/2005 | EP1392285B1 Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |
| 02/09/2005 | CN1578650A Compositions for the treatment of infectious diseases |
| 02/09/2005 | CN1576269A N-<l- deoxyglucose alcoho1-1-radical> amino acid and producing process and use thereof |
| 02/09/2005 | CN1575795A Naloxone hydrochloride nasal spray |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/08/2005 | US6852889 Antioxidant nitroxides and nitrones as therapeutic agents |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/03/2005 | WO2005009419A2 Use of 5-methoxytryptamine as a cardioprotective agents |
| 02/03/2005 | WO2005000335A3 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026927 Pyrazole derivatives as psychopharmaceuticals |
| 02/03/2005 | US20050026822 Human 3 relaxin |
| 02/03/2005 | US20050026226 Serum Paraoxonase |
| 02/02/2005 | EP1501919A1 Soya cell strains with high isoflavone content |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501774A1 Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity |
| 02/02/2005 | EP1501528A1 Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family |
| 02/02/2005 | CN1575179A Combination product comprising melagatran and dexamethasone |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1187330C Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/02/2005 | CN1187094C Polyol-IFN-beta conjugates |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | US20050020666 Cardioprotective agents |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/26/2005 | EP1500397A1 Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases |
| 01/26/2005 | EP1499294A2 Transport system in biological systems |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | CN1571637A Use of cystathionine |
| 01/26/2005 | CN1569217A Manufacturing method of metallothionin contained tablet for removing lead |
| 01/26/2005 | CN1569196A Rhodiola sacra injection and its preparation |
| 01/26/2005 | CN1569195A Rhodiola sacra soft capsule and its preparation |
| 01/26/2005 | CN1569164A Blood lead content reducing medicine for treating plumbism |
| 01/26/2005 | CN1569130A Aqueous extract of leonurus heterophyllus and its application in preparing pharmaceutical composition |
| 01/26/2005 | CN1569127A Compound preparation of purslane extraction and ginsenoside and its anti-anoxia usage |
| 01/26/2005 | CN1186035C Health food capsule with functions of sobering up, detoxicating, nourishing heart, tranquilizing and protecting liver and its production process |